Non-small Cell Lung Cancer and Quality of Life (SILKE)
May 28, 2015 updated by: Maria Silvoniemi, University of Turku
Treatment of Non-small Cell Lung Cancer -Effects on Quality of Life and Symptom Control
The principal objective is to study clinical observations, symptoms and quality of life of non-small-cell lung cancer (NSCLC) patients undergoing specific non-operative treatment for cancer, including chemotherapy and radiotherapy.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
130
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
The patients treated in the clinic of respiratory medicine in Turku, Finland
Description
Inclusion Criteria:
- Patients with verified NSCLC
- after the NSCLC diagnosis has been confirmed prior to first chemotherapy or radiotherapy
- Finnish speaking patients
- aged 18 years or more
- Written informed consent has to be signed
Exclusion Criteria:
- Patients not consenting to participate in the study
- patients not able to communicate sufficiently
- cancer type is other than non-small-cell lung cancer
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Non-small cell lung cancer patients
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2008
Primary Completion (Actual)
February 1, 2012
Study Completion (Actual)
February 1, 2012
Study Registration Dates
First Submitted
January 5, 2009
First Submitted That Met QC Criteria
January 6, 2009
First Posted (Estimate)
January 7, 2009
Study Record Updates
Last Update Posted (Estimate)
May 29, 2015
Last Update Submitted That Met QC Criteria
May 28, 2015
Last Verified
May 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SILKE-ETMK:47/180/2008
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.